Marinus Pharmaceuticals Inc (MRNS)
1.56
+0.08
(+5.41%)
USD |
NASDAQ |
May 07, 16:00
1.59
+0.03
(+1.92%)
After-Hours: 20:00
Marinus Pharmaceuticals Accounts Payable (Quarterly): 4.003M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.003M |
September 30, 2023 | 2.626M |
June 30, 2023 | 2.302M |
March 31, 2023 | 4.466M |
December 31, 2022 | 4.461M |
September 30, 2022 | 2.829M |
June 30, 2022 | 3.299M |
March 31, 2022 | 4.671M |
December 31, 2021 | 3.126M |
September 30, 2021 | 0.693M |
June 30, 2021 | 3.311M |
March 31, 2021 | 5.167M |
December 31, 2020 | 2.211M |
September 30, 2020 | 2.999M |
June 30, 2020 | 3.733M |
March 31, 2020 | 2.845M |
December 31, 2019 | 2.763M |
September 30, 2019 | 3.561M |
June 30, 2019 | 4.973M |
March 31, 2019 | 1.932M |
December 31, 2018 | 2.472M |
Date | Value |
---|---|
September 30, 2018 | 2.917M |
June 30, 2018 | 1.294M |
March 31, 2018 | 0.797M |
December 31, 2017 | 0.927M |
September 30, 2017 | 0.634M |
June 30, 2017 | 1.161M |
March 31, 2017 | 2.236M |
December 31, 2016 | 2.809M |
September 30, 2016 | 3.845M |
June 30, 2016 | 2.824M |
March 31, 2016 | 2.553M |
December 31, 2015 | 3.146M |
September 30, 2015 | 2.30M |
June 30, 2015 | 1.097M |
March 31, 2015 | 3.055M |
December 31, 2014 | 0.536M |
September 30, 2014 | 0.8273M |
June 30, 2014 | 1.742M |
March 31, 2014 | 1.773M |
December 31, 2013 | 0.078M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.693M
Minimum
Sep 2021
5.167M
Maximum
Mar 2021
3.370M
Average
3.299M
Median
Jun 2022
Accounts Payable (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 2.427M |
Soligenix Inc | 1.111M |
Actinium Pharmaceuticals Inc | -- |
Macrogenics Inc | 6.443M |
ADMA Biologics Inc | 15.66M |